Robert H K Chen

Title: The Innovations of Robert H K Chen

Introduction

Robert H K Chen is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of vasopressin antagonists. With a total of five patents to his name, Chen's work has the potential to impact various medical conditions.

Latest Patents

Chen's latest patents include innovative nonpeptide substituted spirobenzoazepines as vasopressin antagonists. These inventions are directed to nonpeptide substituted benzodiazepines of Formula I, which are useful as vasopressin receptor antagonists. They are designed to treat conditions associated with vasopressin receptor activity, such as increased vascular resistance and cardiac insufficiency. The pharmaceutical compositions comprising a compound of Formula I and methods for treating conditions like hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, or water retention are also disclosed in his patents.

Career Highlights

Robert H K Chen is currently associated with Ortho-McNeil Pharmaceutical Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new treatments that can significantly improve patient outcomes.

Collaborations

Some of his notable coworkers include Min Amy Xiang and Maud J Urbanski, who have collaborated with him on various projects.

Conclusion

Robert H K Chen's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing vasopressin antagonists showcases the potential for advancements in treating critical medical conditions.